1. Silencing of the Long Non-Coding RNA TTN-AS1 Attenuates the Malignant Progression of Osteosarcoma Cells by Regulating the miR-16-1-3p/TFAP4 Axis
   Xianghai Meng et al, 2021, Frontiers in Oncology CrossRef
2. Deletion of the transcriptional regulator TFAP4 accelerates c-MYC-driven lymphomagenesis
   Margaret A. Potts et al, 2023, Cell Death & Differentiation CrossRef
3. An integrated pan‐cancer analysis of TFAP4 aberrations and the potential clinical implications for cancer immunity
   Jian‐Nan Liu et al, 2021, Journal of Cellular and Molecular Medicine CrossRef
4. Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: Promises and Challenges
   Mahshid Deldar Abad Paskeh et al, 2023, Pharmacological Research CrossRef
5. TFAP4 Promotes Hepatocellular Carcinoma Invasion and Metastasis via Activating the PI3K/AKT Signaling Pathway
   Tao Huang et al, 2019, Disease Markers CrossRef
6. Upregulating microRNA-373-3p promotes apoptosis and inhibits metastasis of hepatocellular carcinoma cells
   Hongbin Li et al, 2022, Bioengineered CrossRef
7. MicroRNA-302c represses epithelial–mesenchymal transition and metastasis by targeting transcription factor AP-4 in colorectal cancer
   Wenqi Ma et al, 2018, Biomedicine & Pharmacotherapy CrossRef
8. TFAP4 promotes the growth of prostate cancer cells by upregulating FOXK1
   Yuan Gu et al, 2021, Experimental and Therapeutic Medicine CrossRef
9. CRISPR Screen Reveals that EHEC’s T3SS and Shiga Toxin Rely on Shared Host Factors for Infection
   Alline R. Pacheco et al, 2018, mBio CrossRef